Overall, we identified 152 IDH-mutant and 1p/19q-codeleted oligodendroglioma tumors, 234 IDH-mutant astrocytoma tumors, and 186 IDH-wildtype glioblastoma tumors. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).